Oura buys Counsel Health, the AI primary-care startup already inside its app

Oura, the maker of the Oura Ring, said on November 10 that it has entered into a definitive agreement to acquire Counsel Health, an AI primary-care startup whose service already runs inside the Oura app. TechCrunch reported the price as $625 million.

Counsel was already inside the Oura app before the deal

Oura's announcement says it has partnered with Counsel since May 2026. TechCrunch described Counsel Health as "an AI-powered healthcare platform that combines a chat-based medical experience with access to licensed physicians," and said its service was integrated into the Oura app in June.

Oura said Counsel's medical AI is supervised by board-certified physicians and that "Counsel physicians can diagnose, treat, order labs, and prescribe when appropriate." It also gave one usage figure: "more than half of Counsel users in Oura Labs have shared their Oura data with their physicians." Oura did not say how many people use the service.

What the two sides say they are buying

Muthu Alagappan, founder and CEO of Counsel Health, said in Oura's announcement: "Continuous health context makes medical AI more useful and relevant to each person." Tom Hale, Oura's CEO, said: "Getting care is increasingly difficult due to a confluence of higher healthcare costs, a shortage of doctors," and "limited time allotted to live doctor-patient visits."

Alagappan will join Oura as chief clinical AI officer, along with the company's 70 employees, TechCrunch reported, citing Bloomberg. Oura said Counsel will keep working with health plans and health systems.

A $625 million price against $36 million raised

Counsel raised a $25 million Series A a year ago, led by Andreessen Horowitz and GV, TechCrunch reported. PitchBook estimates the company had raised $36 million in total. The reported price is 17.4 times that total (computed).

The founding date and founders' backgrounds are not given in the sources reviewed, and neither company has said what the deal is paid in. Oura said the acquisition is expected to close near the end of this year; TechCrunch reported a different window, before the end of 2027.

Oura's own numbers, and an IPO put off

Oura said its revenue grew 153% from a year earlier to $533 million in the quarter ended September 30, TechCrunch reported. The company reached an $11 billion valuation after a $900 million late-stage round in October 2025, and TechCrunch reported that it postponed an IPO of up to $2.2 billion indefinitely, citing "uncertainty in the IPO market."

A sale that shows a partnership worked, not yet that the care model pays

We think the deal is stronger evidence for Oura's strategy than for Counsel's economics. The one usage figure the companies gave is about data sharing, not about visits, revenue or the number of members who pay for care, and the price is 17.4 times the money Counsel is estimated to have raised.

The opportunity for Counsel is distribution: a service inside an app with a large member base reaches people a standalone startup would have to find one at a time. The threat is that the buyer is the customer, so the sale does not show that outside health plans and systems want the product. We would watch whether Oura discloses paid usage or health-plan contracts, and our view would change if it never does.

The view in this final section is FinanceInTime's editorial opinion, for information only. It is not investment, tax, legal or other advice, and it does not take your circumstances into account. Forecasts are uncertain and past results do not guarantee future ones.